219 related articles for article (PubMed ID: 33731305)
1. The Cost-Effectiveness of Palliative Care: Insights from the PAL-HF Trial.
Kaufman BG; Granger BB; Sun JL; Sanders G; Taylor DH; Mark DB; Warraich H; Fiuzat M; Steinhauser K; Tulsky JA; Rogers JG; O'Connor C; Mentz RJ
J Card Fail; 2021 Jun; 27(6):662-669. PubMed ID: 33731305
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a Heart Failure Telemonitoring Program Through a Microsimulation Model: Cost-Utility Analysis.
Boodoo C; Zhang Q; Ross HJ; Alba AC; Laporte A; Seto E
J Med Internet Res; 2020 Oct; 22(10):e18917. PubMed ID: 33021485
[TBL] [Abstract][Full Text] [Related]
3. Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical Trial.
Rogers JG; Patel CB; Mentz RJ; Granger BB; Steinhauser KE; Fiuzat M; Adams PA; Speck A; Johnson KS; Krishnamoorthy A; Yang H; Anstrom KJ; Dodson GC; Taylor DH; Kirchner JL; Mark DB; O'Connor CM; Tulsky JA
J Am Coll Cardiol; 2017 Jul; 70(3):331-341. PubMed ID: 28705314
[TBL] [Abstract][Full Text] [Related]
4. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
[TBL] [Abstract][Full Text] [Related]
5. Economic Outcomes of Rehabilitation Therapy in Older Patients With Acute Heart Failure in the REHAB-HF Trial: A Secondary Analysis of a Randomized Clinical Trial.
Chew DS; Li Y; Zeitouni M; Whellan DJ; Kitzman D; Mentz RJ; Duncan P; Pastva AM; Reeves GR; Nelson MB; Chen H; Reed SD
JAMA Cardiol; 2022 Feb; 7(2):140-148. PubMed ID: 34817542
[TBL] [Abstract][Full Text] [Related]
6. Vericiguat for the Treatment of Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event: A Cost-Effectiveness Analysis from the Perspective of Chinese Healthcare Providers.
Yu X; Hao Y; Zhu Z; Zhang W; Liu B; Ma M; Zhang X; Wei N; Wang J; Liu F
Clin Drug Investig; 2023 Apr; 43(4):241-250. PubMed ID: 36929485
[TBL] [Abstract][Full Text] [Related]
7. The palliative care in heart failure trial: rationale and design.
Mentz RJ; Tulsky JA; Granger BB; Anstrom KJ; Adams PA; Dodson GC; Fiuzat M; Johnson KS; Patel CB; Steinhauser KE; Taylor DH; O'Connor CM; Rogers JG
Am Heart J; 2014 Nov; 168(5):645-651.e1. PubMed ID: 25440791
[TBL] [Abstract][Full Text] [Related]
8. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
[TBL] [Abstract][Full Text] [Related]
9. Sex Differences in Quality of Life and Clinical Outcomes in Patients With Advanced Heart Failure: Insights From the PAL-HF Trial.
Truby LK; O'Connor C; Fiuzat M; Stebbins A; Coles A; Patel CB; Granger B; Pagidipati N; Agarwal R; Rymer J; Lowenstern A; Douglas PS; Tulsky J; Rogers JG; Mentz RJ
Circ Heart Fail; 2020 Apr; 13(4):e006134. PubMed ID: 32268795
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary artery pressure-guided heart failure management: US cost-effectiveness analyses using the results of the CHAMPION clinical trial.
Martinson M; Bharmi R; Dalal N; Abraham WT; Adamson PB
Eur J Heart Fail; 2017 May; 19(5):652-660. PubMed ID: 27647784
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model.
Pufulete M; Maishman R; Dabner L; Mohiuddin S; Hollingworth W; Rogers CA; Higgins J; Dayer M; Macleod J; Purdy S; McDonagh T; Nightingale A; Williams R; Reeves BC
Health Technol Assess; 2017 Aug; 21(40):1-150. PubMed ID: 28774374
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of remote haemodynamic monitoring by an implantable pulmonary artery pressure monitoring sensor (CardioMEMS-HF system) in chronic heart failure in the Netherlands.
Mokri H; Clephas PRD; de Boer RA; van Baal P; Brugts JJ; Rutten-van Mölken MPMH
Eur J Heart Fail; 2024 May; 26(5):1189-1198. PubMed ID: 38560762
[TBL] [Abstract][Full Text] [Related]
13. Long-term cost-effectiveness of home versus clinic-based management of chronic heart failure: the WHICH? study.
Maru S; Byrnes JM; Carrington MJ; Stewart S; Scuffham PA
J Med Econ; 2017 Apr; 20(4):318-327. PubMed ID: 27841726
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of systematic fast-track transition from oncological treatment to specialised palliative care at home for patients and their caregivers: the DOMUS trial.
Halling CMB; Wolf RT; Sjøgren P; Von Der Maase H; Timm H; Johansen C; Kjellberg J
BMC Palliat Care; 2020 Sep; 19(1):142. PubMed ID: 32933489
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction.
Gaziano TA; Fonarow GC; Claggett B; Chan WW; Deschaseaux-Voinet C; Turner SJ; Rouleau JL; Zile MR; McMurray JJ; Solomon SD
JAMA Cardiol; 2016 Sep; 1(6):666-72. PubMed ID: 27438344
[TBL] [Abstract][Full Text] [Related]
17. Home telemonitoring or structured telephone support programmes after recent discharge in patients with heart failure: systematic review and economic evaluation.
Pandor A; Thokala P; Gomersall T; Baalbaki H; Stevens JW; Wang J; Wong R; Brennan A; Fitzgerald P
Health Technol Assess; 2013 Aug; 17(32):1-207, v-vi. PubMed ID: 23927840
[TBL] [Abstract][Full Text] [Related]
18. A telemonitoring programme in patients with heart failure in France: a cost-utility analysis.
Caillon M; Sabatier R; Legallois D; Courouve L; Donio V; Boudevin F; de Chalus T; Hauchard K; Belin A; Milliez P
BMC Cardiovasc Disord; 2022 Oct; 22(1):441. PubMed ID: 36217130
[TBL] [Abstract][Full Text] [Related]
19. Real-time pulmonary artery pressure monitoring in heart failure patients: an updated cost-effectiveness analysis.
Cowie MR; Thokala P; Ihara Z; Adamson PB; Angermann C
ESC Heart Fail; 2023 Oct; 10(5):3046-3054. PubMed ID: 37591524
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
